Peiying Zuo

534 total citations · 1 hit paper
16 papers, 395 citations indexed

About

Peiying Zuo is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Peiying Zuo has authored 16 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Peiying Zuo's work include Neonatal Respiratory Health Research (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peiying Zuo is often cited by papers focused on Neonatal Respiratory Health Research (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peiying Zuo collaborates with scholars based in United States, United Kingdom and Japan. Peiying Zuo's co-authors include Randeep Sangha, Jonathan E. Rosenberg, Joshua M. Lang, Jingsong Zhang, Joaquina Baranda, David C. Smith, Sandy Srinivas, Elizabeth R. Plimack, Daniel P. Petrylak and Chunzhang Wu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Peiying Zuo

15 papers receiving 382 citations

Hit Papers

EV-101: A Phase I Study of Single-Agent Enfortumab Vedoti... 2020 2026 2022 2024 2020 50 100 150 200

Peers

Peiying Zuo
Comparison fields: 5 of 71
  • Surgery 198
  • Oncology 163
  • Pulmonary and Respiratory Medicine 70
  • Molecular Biology 63
  • Radiology, Nuclear Medicine and Imaging 55
Replace Anna de Fazio with:
Anna de Fazio Australia
Qiwei Yao China
Koichi Tsutahara Japan
Areerak Phanphaisarn Thailand
Minehiko Inomata Japan
Yingying Huang China
Weiming Zhu China
Hiroyuki Tsunemori Japan
Shinichiro Goto Japan
Qingyu Kong China
Anna de Fazio Australia View profile →
Citations per field, relative to Peiying Zuo
Peiying Zuo · 1×
Citations per year, relative to Peiying Zuo
Peiying Zuo · 1×

Countries citing papers authored by Peiying Zuo

Since Specialization
Citations

This map shows the geographic impact of Peiying Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiying Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiying Zuo more than expected).

Fields of papers citing papers by Peiying Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiying Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiying Zuo. The network helps show where Peiying Zuo may publish in the future.

Co-authorship network of co-authors of Peiying Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Peiying Zuo. A scholar is included among the top collaborators of Peiying Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiying Zuo. Peiying Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1 4
2 1
3 11
4 12
5
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma breakdown →
223
6 19
7 1
8 7
9 0
10 3
11 31
12 6
13 22
14 13
15 8
16 34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026